- Phone
- +1 212.872.1096
Profile
Work Department
Position
Ira Dizengoff represents official committees, ad hoc groups of unsecured and secured creditors, debtor in possession lenders, institutional investors, hedge funds and acquirers of businesses and assets, in large, complex cases, out-of-court and in chapter 11. His restructuring matters encompass a variety of industries and involve multijurisdictional and cross-border matters.
Significant matters include Diamond Sports Group, SVB Financial Group, Steward Health Care, Enviva, Altice US, GTT Communications, Avaya, Talen Energy, Travelport, Sears, Intelsat, Scandinavian Airlines, to name a few.
To learn more about Ira, please visit his full profile: https://www.akingump.com/en/lawyers-advisors/ira-s-dizengoff.html
Career
For many years, Ira has been recognized as a leading lawyer by various industry publications/directories, including Chambers Global, Chambers USA, The Legal 500 US, The American Lawyer, Turnarounds & Workouts and Law360.
Memberships
Education
BA, magna cum laude, Brandeis University; JD, Benjamin N. Cardozo School of Law; Member, Cardozo Law Review.
Content supplied by Akin
Testimonials
Collated independently by Legal 500 research team.
- 'Extremely smart and creative team. Deep bench and ability to quickly tackle complicated and challenging issues.'
- 'Very strong commitment and passion to helping their clients. Very intelligent.'
Key clients
- Official Committee of Unsecured Creditors of Alexander E. Jones
- Ad Hoc Group of Noteholders of Ardagh Group
- Brightspeed
- Ad Hoc Group of Cross Holders of CommScope
- CURO Group Holdings Corp
- Official Committee of Unsecured Creditors of Diamond Sports Group
- Ad Hoc Group of 2026 Convertible Noteholders of DISH Network
- Official Committee of Unsecured Creditors of Enviva
- Official Committee of Unsecured Creditors of Rudolph W. Giuliani
- Ad Hoc Group of Lenders of McAfee Enterprises
- Official Committee of Unsecured Creditors of NanoString Technologies
- Official Committee of Unsecured Creditors of Purdue Pharma

